Fadi Hage, MDDr. Hage is Associate Professor of Medicine in the Division of Cardiovascular Disease, Director of Nuclear Cardiology at UAB, and Director of the Cardiac Care Unit at the BVAMC. He is also a member of the Vascular Biology and Hypertension Program.
In 2014, Dr. Hage and collaborators demonstrated that the effects of estrogen therapy on vascular inflammation are age dependent. In 2002, the Women’s Health Initiative (WHI) reported increased cardiovascular events in women treated with menopausal hormones compared to placebo. These results were in contrast to the well-established anti-inflammatory and vasoprotective effects of 17β-Estradiol (E2) seen in in vitro preparations, young adult laboratory animals, and observational studies in pre- and peri-menopausal women. Importantly, WHI enrolled older women than the observational studies.
Takumi Yamada, MDTakumi Yamada obtained his medical doctorate from the University of Nagoya in Japan. He completed residency training in internal medicine and fellowships in cardiology, interventional cardiology and electrophysiology at the Nagoya Dai-ni Red Cross Hospital where he served as chief fellow. In 2006, Dr. Yamada came to UAB as a post-doctoral fellow, and he joined the section of electrophysiology of UAB as Instructor of Medicine in 2008. Dr. Yamada was awarded an Alabama medical license as Distinguished Professor of Medicine at UAB in 2010. He then joined the clinical electrophysiology faculty as Assistant Professor of Medicine in 2011 and was promoted to Associate Professor of Medicine with Tenure in 2014.
Tiffany L. Carson, PhD, MPHDr. Tiffany L. Carson is an Assistant Professor the Division of Preventive Medicine in the UAB School of Medicine. She also holds appointments as an associate scientist in the UAB Comprehensive Cancer Center (CCC), the UAB Minority Health and Health Disparities Research Center (MHRC), and the UAB Nutrition Obesity Research Center (NORC).
Dr. Carson is an applied epidemiologist with masters and doctoral degrees in epidemiology from the UAB School of Public Health. She also completed a post-doctoral fellowship at the University of Arkansas for Medical Sciences.
Nicholas Van Wagoner, MD, PhDDr. Nick Van Wagoner is an Assistant Professor in the Division of Infectious Diseases where he works with Drs. Edward W. Hook, Jane Schwebke, William Geisler, Christina Muzny, and Barbara Van der Pol in the Sexually Transmitted Infections Group.
Dr. Van Wagoner received his Ph.D. in Cell Biology and his M.D. from UAB. Dr. Van Wagoner's work is funded through an NIH K23 career development award. He also serves as the site primary investigator for several vaccine trials.
Dr. Van Wagoner's primary research focus is in novel treatments for herpes simplex virus type 2 (HSV-2). HSV-2 is a common sexually transmitted infection (STI) with 1 in 5 women and 1 in 10 men in the U.S. infected. Annual incidence in the U.S. is well over 750,000.